| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016NatCo...712991K |
| P356 | DOI | 10.1038/NCOMMS12991 |
| P932 | PMC publication ID | 5064015 |
| P698 | PubMed publication ID | 27694828 |
| P50 | author | Jamunarani Veeraraghavan | Q82240483 |
| Rachel Schiff | Q90949247 | ||
| Yulong Liang | Q43190601 | ||
| P2093 | author name string | Xian Wang | |
| Kaiyi Li | |||
| Shixia Huang | |||
| Xuewen Pan | |||
| Dean P Edwards | |||
| Ying Tan | |||
| Jin-Ah Kim | |||
| Xiao-Song Wang | |||
| Xixi Cao | |||
| P2860 | cites work | Mammalian homologues of the plant Tousled gene code for cell-cycle-regulated kinases with maximal activities linked to ongoing DNA replication | Q22010662 |
| DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 | ||
| p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2 | Q24294568 | ||
| Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor | Q24301920 | ||
| TTD: Therapeutic Target Database | Q24548461 | ||
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27 | Q28137813 | ||
| Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1 | Q28145116 | ||
| The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27 | Q28202908 | ||
| Cyclin A in cell cycle control and cancer | Q28205375 | ||
| Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases | Q28208430 | ||
| Cell cycle kinases as therapeutic targets for cancer | Q28250447 | ||
| Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites | Q28278266 | ||
| p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 | Q28505037 | ||
| Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures | Q29547700 | ||
| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 | ||
| Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
| An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer | Q33514281 | ||
| MISSION esiRNA for RNAi screening in mammalian cells | Q33577868 | ||
| Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance | Q33648503 | ||
| Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers | Q34034269 | ||
| A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. | Q34582206 | ||
| The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo | Q34621429 | ||
| Transforming Properties of 8p11-12 Amplified Genes in Human Breast Cancer | Q34950377 | ||
| Blockbuster dreams for Pfizer's CDK inhibitor. | Q54445420 | ||
| Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases | Q73316457 | ||
| Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation | Q77960210 | ||
| Characterization of KRAS rearrangements in metastatic prostate cancer | Q35581673 | ||
| Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity | Q35591349 | ||
| Subtype and pathway specific responses to anticancer compounds in breast cancer | Q35779241 | ||
| Proteogenomics connects somatic mutations to signalling in breast cancer | Q36037203 | ||
| Identification of new candidate therapeutic target genes in triple-negative breast cancer | Q36153325 | ||
| Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage | Q36201008 | ||
| The UCSC Cancer Genomics Browser: update 2013. | Q36491520 | ||
| Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation | Q36573000 | ||
| Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules | Q36758884 | ||
| The C. elegans Tousled-like kinase contributes to chromosome segregation as a substrate and regulator of the Aurora B kinase. | Q37122543 | ||
| SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. | Q37193756 | ||
| Genetic variation in the chromosome 17q23 amplicon and breast cancer risk | Q37311599 | ||
| miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer | Q37613562 | ||
| Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells. | Q37663786 | ||
| The dual kinase complex FAK-Src as a promising therapeutic target in cancer | Q37771259 | ||
| Advances in targeting SRC in the treatment of breast cancer and other solid malignancies | Q37773087 | ||
| Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary | Q39041004 | ||
| Emerging roles of focal adhesion kinase in cancer | Q39611596 | ||
| Cyclin A Promotes S-Phase Entry via Interaction with the Replication Licensing Factor Mcm7 | Q39631585 | ||
| Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis | Q39716467 | ||
| Spatial control of EGF receptor activation by reversible dimerization on living cells | Q39731307 | ||
| Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells | Q39990344 | ||
| Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression | Q40213078 | ||
| Skp2-dependent degradation of p27kip1 is essential for cell cycle progression | Q40294406 | ||
| A role for the scaffolding adapter GAB2 in breast cancer | Q40337530 | ||
| RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity | Q40615849 | ||
| Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade | Q42510471 | ||
| A census of amplified and overexpressed human cancer genes | Q44951771 | ||
| Cdc2-cyclin E complexes regulate the G1/S phase transition | Q46592665 | ||
| Treatment of chronic myeloid leukemia in 2007 | Q46927953 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12991 | |
| P577 | publication date | 2016-10-03 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers | |
| P478 | volume | 7 |
| Q38679219 | Differential requirements for Tousled-like kinases 1 and 2 in mammalian development |
| Q90477983 | Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity |
| Q47335450 | Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells. |
| Q55400118 | Molecular basis of Tousled-Like Kinase 2 activation. |
| Q91650355 | Systematic discovery of the functional impact of somatic genome alterations in individual tumors through tumor-specific causal inference |
| Q60907652 | The circadian E3 ligase complex SCF targets TLK2 |
| Q58796099 | Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors |
Search more.